ZA857912B - Dipeptide compounds having pharmaceutical activity and compositions containing them - Google Patents

Dipeptide compounds having pharmaceutical activity and compositions containing them

Info

Publication number
ZA857912B
ZA857912B ZA857912A ZA857912A ZA857912B ZA 857912 B ZA857912 B ZA 857912B ZA 857912 A ZA857912 A ZA 857912A ZA 857912 A ZA857912 A ZA 857912A ZA 857912 B ZA857912 B ZA 857912B
Authority
ZA
South Africa
Prior art keywords
compositions containing
pharmaceutical activity
dipeptide compounds
dipeptide
compounds
Prior art date
Application number
ZA857912A
Other languages
English (en)
Inventor
Alberto Pilotto
Mario Portelli
Angelo Carenzi
Davide Della Bella
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of ZA857912B publication Critical patent/ZA857912B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA857912A 1984-10-16 1985-10-15 Dipeptide compounds having pharmaceutical activity and compositions containing them ZA857912B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23173/84A IT1176983B (it) 1984-10-16 1984-10-16 Dipeptidi ad attivita' farmacologica

Publications (1)

Publication Number Publication Date
ZA857912B true ZA857912B (en) 1986-05-28

Family

ID=11204532

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857912A ZA857912B (en) 1984-10-16 1985-10-15 Dipeptide compounds having pharmaceutical activity and compositions containing them

Country Status (11)

Country Link
US (1) US4761399A (de)
EP (1) EP0198898B1 (de)
JP (1) JPS62500871A (de)
AU (1) AU582600B2 (de)
CA (1) CA1262550A (de)
DK (1) DK269186A (de)
ES (1) ES8701196A1 (de)
FI (1) FI84836C (de)
IT (1) IT1176983B (de)
WO (1) WO1986002353A1 (de)
ZA (1) ZA857912B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196485B (it) * 1986-07-14 1988-11-16 Zambon Spa Derivati dell'acido tiazolidin-4-carbossilico ad attivita' farmaceutica
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
WO1991002810A1 (en) * 1989-08-09 1991-03-07 The Children's Medical Center Corporation Nmda oxidizing agents for protecting neurons from injury
US5238683A (en) * 1989-11-24 1993-08-24 The United States Of America As Represented By The Department Of Health And Human Services Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
AU661379B2 (en) * 1992-04-23 1995-07-20 Transcend Therapeutics, Inc Method of reducing or preventing toxicity associated with antiretroviral therapy
US5618823A (en) * 1992-06-24 1997-04-08 Boehringer Mannheim Italia S.P.A. Glutathione as chemoprotective agent
ES2052454B1 (es) * 1992-12-31 1995-01-16 Zambon S A Dipeptidos y composiciones que los contienen con accion farmaceutica contra el envejecimiento.
US6251857B1 (en) 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
RU2089179C1 (ru) * 1995-12-14 1997-09-10 Закрытое акционерное общество "ВАМ" Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
JP2002501518A (ja) * 1997-05-30 2002-01-15 セルテック セラピューティックス リミテッド 抗炎症性チロシン誘導体
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
US6555562B1 (en) 1998-02-26 2003-04-29 Celltech R&D Limited Phenylalanine derivatives
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) * 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
US20070142267A1 (en) * 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
RU2144374C1 (ru) 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
WO2001079173A2 (en) 2000-04-17 2001-10-25 Celltech R & D Limited Enamine derivatives as cell adhesion molecules
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
EP1301488A1 (de) 2000-07-07 2003-04-16 Celltech R&D Limited Bicyclische heteroaromatische ring enthaltende quadratsäure-derivate als integrin-antagonisten
CA2417059A1 (en) 2000-08-02 2002-02-07 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
WO2006101910A2 (en) * 2005-03-16 2006-09-28 Ischemix, Inc. Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems
EP1883406B1 (de) * 2005-05-23 2016-07-06 Natural Alternatives International, Inc. Zusammensetzungen und verfahren zur anhaltenden freisetzung von beta-alanin
US20110064828A1 (en) * 2009-09-11 2011-03-17 Novelos Therapeutics, Incorporated Treatment of metastatic tumors and other conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
GR75019B (de) * 1980-09-17 1984-07-12 Univ Miami
DE19575012I2 (de) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel

Also Published As

Publication number Publication date
FI84836C (fi) 1992-01-27
IT1176983B (it) 1987-08-26
FI861383A (fi) 1986-04-17
EP0198898B1 (de) 1988-08-24
AU582600B2 (en) 1989-04-06
ES548530A0 (es) 1986-11-16
WO1986002353A1 (en) 1986-04-24
CA1262550A (en) 1989-10-31
IT8423173A0 (it) 1984-10-16
FI84836B (fi) 1991-10-15
DK269186D0 (da) 1986-06-09
JPS62500871A (ja) 1987-04-09
AU5016585A (en) 1986-05-02
US4761399A (en) 1988-08-02
FI861383A0 (fi) 1986-04-01
DK269186A (da) 1986-06-09
EP0198898A1 (de) 1986-10-29
ES8701196A1 (es) 1986-11-16

Similar Documents

Publication Publication Date Title
ZA857912B (en) Dipeptide compounds having pharmaceutical activity and compositions containing them
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
PH22863A (en) Pyrrolobenzimidazoles and pharmaceutical composition containing them
IL74365A0 (en) 17beta-n-monosubstituted carbamoyl or 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
PH22480A (en) New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds
ZA864602B (en) 2-arylimidazoles and pharmaceutical compositions containing these compounds
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
ZA857522B (en) Pharmaceutical compositions containing diazepines and having a paf-antagonistic activity
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
IL79376A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ225466A (en) 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
IL79980A0 (en) Pharmaceutical composition containing ypsilon-interferon
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
PH23343A (en) 8 0( acylaminoergolines and pharmaceutical compositions containing them
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them